https://medicaldialogues.in/news/industry/pharma/copd-treatment-cdsco-nod-to-astrazeneca-india-to-market-triple-drug-combination-inhalation-aerosol-121619
0
0
12/15/23 at 6:39am
Organization
Medical Dialogues
Author
Ruchika Sharma
41 words
0
Comments
Bangalore: Biopharmaceutical company AstraZeneca India has announced that it has received Central Drugs Standard Control Organisation (CDSCO) approval to market its inhalation aerosol, a triple...
You are the first to view
Create an account
or login to join the discussion